CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?

Farinola, Nicholas; Piller, Neil B

Farinola, Nicholas; Piller, Neil B.

Affiliation

Farinola N; Lymphedema Assessment Clinic, Department of Surgery, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia.

Pharmacogenomics ; 8(2): 151-8, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17286538

Subject(s)

Coumarins/adverse effects; Liver Diseases/genetics; Lymphedema/genetics; Pharmacogenetics; Polymorphism, Genetic/genetics; Animals; Chemical and Drug Induced Liver Injury; Humans; Liver Diseases/prevention & control; Lymphedema/drug therapy; Pharmacogenetics/methods

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Polymorphism, Genetic / Coumarins / Liver Diseases / Lymphedema Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2007 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links